Mary Chi Michael

Mary Chi Michael has extensive work experience in the pharmaceutical industry. Mary Chi worked at Pfizer, Inc. (formerly Wyeth Pharmaceuticals) as an Executive Director from December 2001 to January 2010, where they held a leadership role. Mary Chi also worked at Bristol-Myers Squibb, starting in 1988, where they held a marketing position. In this role, Mary led various advocacy and opinion leader engagements, collaborated with government entities, and worked on public health initiatives related to hypertension. Additionally, Mary has served as a Board Member for Sozosei Foundation since January 2020 and for NAMI Mercer NJ since July 2021. Mary Chi is currently a Vice President at Otsuka, overseeing patient advocacy and stakeholder management.

Mary Chi Michael completed their Bachelor of Science (B.S.) degree in Microbiology, General from Virginia Tech from 1982 to 1986. During the same period, they also pursued a minor in Biology (Microbiology) from the Virginia Tech College of Science. Prior to their college education, they attended W-L High School from 1979 to 1982. It is unclear from the provided information whether they obtained a degree in Microbiology, General from W-L High School. There is no information available regarding their education at Singularity University.